​ Conditions: Lung Cancer (Locally Advanced or Metastatic)

Interventions: Drug: tislelizumab in combination with nab-paclitaxel and platinum chemotherapy

Sponsors: Guangzhou Medical University

Active, not recruiting Conditions: Lung Cancer (Locally Advanced or Metastatic)
Interventions: Drug: tislelizumab in combination with nab-paclitaxel and platinum chemotherapy
Sponsors: Guangzhou Medical University
Active, not recruiting